Cansortium Stock Performance
| CNTMF Stock | USD 0.03 0.0002 0.67% |
The firm shows a Beta (market volatility) of -1.05, which signifies a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Cansortium are expected to decrease slowly. On the other hand, during market turmoil, Cansortium is expected to outperform it slightly. At this point, Cansortium has a negative expected return of -0.61%. Please make sure to confirm Cansortium's value at risk, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Cansortium performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Cansortium has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's primary indicators remain nearly stable which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 3.4 M | |
| Total Cashflows From Investing Activities | -22.1 M |
Cansortium |
Cansortium Relative Risk vs. Return Landscape
If you would invest 5.50 in Cansortium on November 12, 2025 and sell it today you would lose (2.52) from holding Cansortium or give up 45.82% of portfolio value over 90 days. Cansortium is currently producing negative expected returns and takes up 9.4871% volatility of returns over 90 trading days. Put another way, 85% of traded otc stocks are less volatile than Cansortium, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Cansortium Target Price Odds to finish over Current Price
The tendency of Cansortium OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.03 | 90 days | 0.03 | about 99.0 |
Based on a normal probability distribution, the odds of Cansortium to move above the current price in 90 days from now is about 99.0 (This Cansortium probability density function shows the probability of Cansortium OTC Stock to fall within a particular range of prices over 90 days) .
Cansortium Price Density |
| Price |
Predictive Modules for Cansortium
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cansortium. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Cansortium Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Cansortium is not an exception. The market had few large corrections towards the Cansortium's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cansortium, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cansortium within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.37 | |
β | Beta against Dow Jones | -1.05 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | -0.06 |
Cansortium Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cansortium for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cansortium can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cansortium generated a negative expected return over the last 90 days | |
| Cansortium has high historical volatility and very poor performance | |
| Cansortium has some characteristics of a very speculative penny stock | |
| Cansortium has high likelihood to experience some financial distress in the next 2 years | |
| Cansortium has accumulated 53.67 M in total debt with debt to equity ratio (D/E) of 1.89, which is about average as compared to similar companies. Cansortium has a current ratio of 0.72, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Cansortium until it has trouble settling it off, either with new capital or with free cash flow. So, Cansortium's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cansortium sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cansortium to invest in growth at high rates of return. When we think about Cansortium's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 65.44 M. Net Loss for the year was (19.04 M) with profit before overhead, payroll, taxes, and interest of 35.79 M. | |
| Cansortium has accumulated about 8.86 M in cash with (5.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 21.0% of Cansortium shares are held by company insiders |
Cansortium Fundamentals Growth
Cansortium OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Cansortium, and Cansortium fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cansortium OTC Stock performance.
| Return On Equity | -0.28 | |||
| Return On Asset | 0.021 | |||
| Profit Margin | (0.29) % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 118.5 M | |||
| Shares Outstanding | 225.38 M | |||
| Price To Book | 0.96 X | |||
| Price To Sales | 0.41 X | |||
| Revenue | 65.44 M | |||
| EBITDA | 11.66 M | |||
| Cash And Equivalents | 8.86 M | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 53.67 M | |||
| Debt To Equity | 1.89 % | |||
| Book Value Per Share | 0.15 X | |||
| Cash Flow From Operations | (5.03 M) | |||
| Earnings Per Share | (0.1) X | |||
| Total Asset | 182.46 M | |||
About Cansortium Performance
By analyzing Cansortium's fundamental ratios, stakeholders can gain valuable insights into Cansortium's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cansortium has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cansortium has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in the United States. Cansortium Inc. was incorporated in 2018 and is headquartered in Miami, Florida. Cansortium operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.Things to note about Cansortium performance evaluation
Checking the ongoing alerts about Cansortium for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Cansortium help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cansortium generated a negative expected return over the last 90 days | |
| Cansortium has high historical volatility and very poor performance | |
| Cansortium has some characteristics of a very speculative penny stock | |
| Cansortium has high likelihood to experience some financial distress in the next 2 years | |
| Cansortium has accumulated 53.67 M in total debt with debt to equity ratio (D/E) of 1.89, which is about average as compared to similar companies. Cansortium has a current ratio of 0.72, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Cansortium until it has trouble settling it off, either with new capital or with free cash flow. So, Cansortium's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cansortium sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cansortium to invest in growth at high rates of return. When we think about Cansortium's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 65.44 M. Net Loss for the year was (19.04 M) with profit before overhead, payroll, taxes, and interest of 35.79 M. | |
| Cansortium has accumulated about 8.86 M in cash with (5.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 21.0% of Cansortium shares are held by company insiders |
- Analyzing Cansortium's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cansortium's stock is overvalued or undervalued compared to its peers.
- Examining Cansortium's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cansortium's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cansortium's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Cansortium's otc stock. These opinions can provide insight into Cansortium's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Cansortium OTC Stock analysis
When running Cansortium's price analysis, check to measure Cansortium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cansortium is operating at the current time. Most of Cansortium's value examination focuses on studying past and present price action to predict the probability of Cansortium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cansortium's price. Additionally, you may evaluate how the addition of Cansortium to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |